Skip to content
Pass Duke Elder
Textbook / Chapter 11 / Strabismus and paediatric ophthalmology

The white pupil and retinoblastoma

A white pupil in a child, leukocoria, is retinoblastoma until proved otherwise, and it is the reason every newborn in the UK has the red reflex checked. This lesson explains the red reflex, sets out the differential diagnosis of a white pupil, and then covers retinoblastoma in detail: how it presents, the RB1 gene and the two-hit hypothesis, how it is diagnosed without a biopsy, and how it is treated.

10 minute read8 linked questions

The red reflex and what a white pupil means

Shine a light into an eye along the line you are looking down and the pupil glows orange-red. This is the red reflex: light passes through the clear cornea, lens and vitreous, is reflected by the blood-filled choroid behind the retina, and returns the same way. The colour varies with skin pigmentation and is paler or more yellow in children with darker skin. What matters is that it is present, even and the same in both eyes.

Anything that blocks the path or replaces the normal fundus with something pale changes the reflex. Leukocoria means a white pupil: a white, grey or yellow reflex in place of the red one. Parents often notice it first in a flash photograph, where one pupil shows red-eye and the other shows white.

In the UK the reflex is checked twice in every baby as part of the Newborn and Infant Physical Examination (NIPE): within 72 hours of birth and again at 6 to 8 weeks. The examiner uses an ophthalmoscope at arm's length in a dimmed room. The result is screen positive if the reflex is absent, partly obscured, white, abnormal in shape or different between the two eyes.

  • A baby who is screen positive at the newborn examination should be seen by an ophthalmologist within 2 weeks.
  • A baby who is screen positive at the 6 to 8 week examination should be seen by 11 weeks of age.

The differential diagnosis of leukocoria

The causes can be worked out from front to back: something white in the lens, in the vitreous, or in or under the retina. Six are worth knowing well.

CauseWhat it isClues
RetinoblastomaMalignant tumour of the developing retinaNormal-sized eye, usually not inflamed, calcification on ultrasound, one or both eyes
Congenital cataractLens opacityOpacity visible in the pupil just behind the iris, present from birth, one or both eyes
Persistent fetal vasculatureFailure of the fetal hyaloid vessels and primary vitreous to regressSmall eye (microphthalmia), one eye in about 90%, membrane behind the lens with ciliary processes drawn in, no calcification
Coats diseaseLeaky, dilated (telangiectatic) retinal vessels with exudateBoys at least three times as often as girls, one eye in 95%, usually diagnosed before 8 years, exudate in and under the retina, no calcification, not inherited
Ocular toxocariasisGranuloma or vitreous inflammation from a roundworm larva (Toxocara canis or cati)Older child, contact with puppies or soil, one eye in about 90%, inflamed eye, calcification very rare
Retinopathy of prematurityFibrovascular mass and detachment in end-stage diseaseHistory of extreme prematurity, both eyes
Causes of a white pupil in a child

Other causes include a coloboma (a gap in the choroid and retina through which white sclera shows), total retinal detachment, a retinal astrocytic hamartoma in tuberous sclerosis, and inherited vitreoretinal disorders. A squinting eye can also give an unequal reflex simply because the light is striking off-centre retina, but this is a diagnosis for a specialist to make after examining the fundus.

The size of the eye is a useful first clue. Retinoblastoma arises in an eye of normal size. Persistent fetal vasculature occurs in a small eye, and it is described as the second commonest cause of leukocoria in infancy. Inflammation points towards toxocariasis. The decisive test is ultrasound: calcification within a mass in a young child strongly suggests retinoblastoma, because it is present in about 90% of these tumours and is rare in the mimics.

Retinoblastoma: who gets it and how it presents

Retinoblastoma is the commonest primary malignant tumour inside the eye in childhood. It arises from immature retinal cells, so it is a disease of young children, mostly under the age of 6. It is rare: the Childhood Eye Cancer Trust gives a figure of about 40 to 50 new cases a year in the UK, roughly one child a week. Boys and girls are affected equally. About 60% of cases affect one eye and about 40% both.

  • Leukocoria is the commonest presentation. The white tumour itself fills the pupil.
  • Squint is the other common presentation. A tumour at the macula destroys central vision and the eye drifts. This is why every child with a squint has a dilated fundus examination.
  • A red, painful or inflamed eye is a rare presentation and suggests advanced disease.
  • Some children are found by screening because a parent or sibling has had the disease.

The tumour can grow inwards into the vitreous (endophytic), shedding seeds of tumour that float in the gel, or outwards under the retina (exophytic), lifting it into a detachment. It leaves the eye mainly along the optic nerve towards the brain, and through the choroid into the blood.

RB1 and the two-hit hypothesis

Retinoblastoma is caused by loss of function of RB1, a gene on the long arm of chromosome 13 (13q14). RB1 is a tumour suppressor gene: its protein acts as a brake on the cell cycle, stopping a cell from copying its DNA and dividing until the right signals arrive. Every cell has two copies of RB1, one from each parent, and one working copy is enough. A retinal cell becomes malignant only when both copies are knocked out.

Alfred Knudson worked this out from the ages at which children presented. Children with tumours in both eyes presented earlier, as if they needed only one random event, while children with a tumour in one eye presented later, as if they needed two. This is the two-hit hypothesis.

Heritable (germline)Non-heritable (somatic)
First hitPresent in every cell of the body, inherited or a new mutation at conceptionOccurs in a single retinal cell after conception
Second hitNeeded in only one retinal cell, so very likely to happenMust happen in that same cell, so very unlikely
Share of casesAbout 45%: every bilateral case plus a minority of unilateral onesAbout 55%
TumoursOften both eyes and several tumoursOne tumour in one eye
Age at presentationEarlierLater
Risk to the child's future children50% inherit the mutationNot increased
Other cancersRaised lifelong riskNot increased
Heritable and non-heritable retinoblastoma compared

Three points catch students out. First, all bilateral cases are heritable, but not all unilateral cases are sporadic: about 15% of children with a tumour in one eye carry a germline mutation. Second, many heritable cases arise from a new mutation, so the absence of a family history does not exclude heritable disease. Third, the predisposition is inherited as an autosomal dominant trait with about 90% penetrance, even though at the level of the cell both copies must be lost. The family tree looks dominant because the second hit is so likely to happen in at least one of the millions of developing retinal cells.

Genetic testing of the child's blood, and the tumour if the eye is removed, shows whether the mutation is germline. Brothers, sisters and future children of a carrier are examined regularly from birth, often under anaesthetic, so that tumours are found while small.

Making the diagnosis

Retinoblastoma is one of the few cancers diagnosed and treated without a tissue sample. Biopsy is avoided because a needle track through the eye wall gives tumour cells a route out of the eye. The diagnosis is clinical, made by an examination under anaesthetic with the pupils dilated, supported by imaging.

  • Fundus examination shows one or more white, rounded retinal masses, with or without seeds in the vitreous or fluid under the retina.
  • Ultrasound shows a mass with bright echoes and shadowing behind them from calcification.
  • MRI of the orbits and brain assesses the optic nerve and looks for a midline brain tumour. MRI is preferred to CT, because radiation is avoided in children who may carry a cancer predisposition gene.

Eyes are graded from A to E by the International Classification of Retinoblastoma. Group A is small tumours away from the fovea and disc. Group E is an eye more than half filled with tumour or with complications such as neovascular glaucoma. The histology, including the Flexner-Wintersteiner rosettes seen in removed eyes, is covered in the chapter on pathology.

Treatment and what follows

The priorities are, in order: the child's life, the eye, and then vision. In the UK survival is about 98%. Treatment is given in specialist centres and is chosen according to the size and position of the tumours, whether one or both eyes are affected and how much vision can be saved.

  • Focal treatment for small tumours: laser or cryotherapy applied directly to the tumour.
  • Chemotherapy to shrink larger tumours so that focal treatment can finish the job. It may be given intravenously (regimens use carboplatin, vincristine and etoposide), into the ophthalmic artery through a catheter (intra-arterial melphalan), or into the vitreous for vitreous seeds.
  • Plaque brachytherapy: a radioactive plaque stitched to the sclera over a tumour.
  • Enucleation, removal of the eye, for advanced eyes with no useful vision, typically group E, or when other treatment fails. A long piece of optic nerve is taken, and the pathologist checks whether tumour has reached its cut end or invaded the choroid.

External beam radiotherapy is now avoided where possible. In children with a germline RB1 mutation it more than triples the risk of a second cancer in the irradiated field, most of all when given in the first year of life.

Children with heritable retinoblastoma carry the RB1 mutation in every cell, so their risk does not end when the eyes are treated. They can develop a midline brain tumour, usually a pinealoblastoma, which with tumours in both eyes is called trilateral retinoblastoma. In later life they have a raised risk of other cancers. Osteosarcoma is the commonest, followed by other sarcomas and melanoma. They need lifelong awareness of this risk and genetic counselling before having children.

Summary

  • Leukocoria is a white pupil in place of the normal red reflex and must be treated as retinoblastoma until proved otherwise.
  • The red reflex is checked within 72 hours of birth and at 6 to 8 weeks, mainly to detect congenital cataract.
  • The main differential is retinoblastoma, congenital cataract, persistent fetal vasculature, Coats disease, toxocariasis and retinopathy of prematurity.
  • Retinoblastoma occurs in a normal-sized eye and shows calcification, whereas persistent fetal vasculature occurs in a small eye and Coats disease is a unilateral exudative condition mainly of boys.
  • Retinoblastoma presents most often with leukocoria, and a squint is the other common presentation.
  • RB1 on chromosome 13q14 is a tumour suppressor gene, and both copies must be lost in a retinal cell for a tumour to form.
  • All bilateral cases and about 15% of unilateral cases are heritable, and the predisposition is inherited as an autosomal dominant trait with about 90% penetrance.
  • The diagnosis is made by examination and imaging, and biopsy is avoided because it risks spreading tumour outside the eye.
  • Treatment ranges from laser and cryotherapy through chemotherapy to enucleation, and survival in the UK is about 98%.
  • Heritable retinoblastoma carries a risk of pinealoblastoma and of later cancers, most often osteosarcoma, and the risk is increased by radiotherapy.

Check yourself

Quick recall on this lesson. These are easier than the question bank.

1. The RB1 gene is located on which chromosome?
2. Which finding on ultrasound most strongly favours retinoblastoma over its mimics in a young child with leukocoria?
3. A child treated for bilateral retinoblastoma is at particular risk in later life of:
4. Leukocoria in a microphthalmic eye of an otherwise well term infant most suggests:
Practise 8 questions on this lesson

Written for revision. It is not a source of clinical advice, and guidance changes.